OECI Workshop on late side-effects of cancer treatments

European Journal of Cancer

Volumn 45, Issue 3, 2009, Pages 354-359

  Arriagada, R ^a,b   Averbeck, D ^c   Dahl, A A ^d,e   Darby, S ^f   Fossa S ^d,e   Friberg, S ^a   Polgar C ^g   de Vathaire, F ^b,h  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT CURIE   (France)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^h INSERM   (France)

Author keywords

Cardiovascular complications; Long term follow up; Meta analysis; Randomised trial; Second cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIANDROGEN; AROMATASE INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; FLUOROURACIL; IODINE 131; METHOTREXATE; TAMOXIFEN;

ANXIETY DISORDER; APOPTOSIS; ARM EDEMA; ARTICLE; ATHEROSCLEROSIS; AZOOSPERMIA; BONE CANCER; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DEATH; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONSTRICTIVE PERICARDITIS; COPING BEHAVIOR; DEPRESSION; DETERIORATION; DNA REPAIR; DOSE RESPONSE; EJACULATION DISORDER; ENDOMETRIUM CANCER; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; FAT NECROSIS; FATIGUE; FROZEN SHOULDER; GASTROINTESTINAL SYMPTOM; GONAD DOSE; GYNECOMASTIA; HEART MUSCLE CELL; HEART VALVE STENOSIS; HEREDITY; HODGKIN DISEASE; HORMESIS; HUMAN; HYPOPITUITARISM; HYPOTHYROIDISM; INTESTINE CANCER; ISCHEMIA; KIDNEY CANCER; KIDNEY DISEASE; KNOWLEDGE; LATE SIDE EFFECT; LEUKEMIA; LONG TERM CARE; MELANOMA; MENTAL STRESS; METASTASIS; MULTIMODALITY CANCER THERAPY; NEUROSIS; NEUROTOXICITY; OSTEOPOROSIS; OSTEOSARCOMA; OTOTOXICITY; OVARY CANCER; OVARY INSUFFICIENCY; PAIN; PARESIS; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RENOVASCULAR HYPERTENSION; SALIVARY GLAND DISEASE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA; SOLID TUMOR; STANDARDIZED MORTALITY RATIO; TESTIS CANCER; THORAX RADIOGRAPHY; THYROID CANCER; TINNITUS; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EUROPE; FEMALE; HUMANS; MALE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; ONCOLOGY SERVICE, HOSPITAL; RADIOTHERAPY; SURVIVAL RATE;

EID: 59349089693     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.005     Document Type: Article

References (48)

1. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worlwide population-based study (CONCORD). Lancet Oncol 9 (2008) 730-756
2. Fosså S.D. Long-term sequelae after cancer therapy. Survivorship after treatment for testicular cancer. Acta Oncologica 43 (2004) 134-141
3. Fosså S.D., Gilbert E., Dores G.M., et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 99 (2007) 533-544
4. Travis L.B., Fosså S.D., Schonfeld S.J., et al. Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
5. van den Belt-Dusebout A.W., de Wit R., Gietema J.A., et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25 (2007) 4341-4343
6. Franklin J., Pluetschow A., Paus M., et al. Second malignancy risk associated with treatment of Hodgkińs lymphoma: meta-analysis of randomised trials. Ann Oncol 17 (2006) 1749-1760
7. Dores G.M., Metayer C., Curtis R.E., et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20 (2002) 3484-3494
8. Travis L.B., Dores G.M., Gospodarowicz M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290 (2003) 465-475
9. Fornander T., and Rutqvist L.E. Adjuvant tamoxifen and second cancers. Lancet 8638 (1989) 616
10. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109 (2007) 1878-1886
11. Early Breast Cancer Trialists'Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer in local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
12. Hooning M.J., Botma A., Aleman M.P., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99 (2007) 365-375
13. Yeh E.T.H., Tong A.T., Lenihan D.J., et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109 (2004) 3122-3131
14. Dahl A.A., Bremnes R., Dahl O., et al. Is the sexual function compromised in long-term testicular cancer survivors?. Eur Urol 52 (2007) 1438-1447
15. Fosså SD, Loge JH, Dahl AA. Long-term survivorship after cancer: how far we come? Ann Oncol 2008;(Suppl 5):25-9.
16. Dahl A.A., Haaland C.F., Mykletun A., et al. Study of anxiety and depression in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 2389-2395
17. Orre I.J., Fosså S.D., Murison R., et al. Chronic fatigue in long-term survivors of testicular cancer. J Psychosom Res 64 (2008) 363-371
18. Mykletun A., Dahl A.A., Haaland C.F., et al. Side-effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 3061-3068
19. Brenner D.J., Doll R., Goodhead D.T., et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc Natl Acad Sci USA 100 (2003) 13761-13766
20. Sachs R.K., and Brenner D.J. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 102 (2005) 13040-13045
21. Tubiana M., Aurengo A., Averbeck D., et al. The dabate on the use of linear no threshold for assessing the effects of low doses. J Radiol Prot 26 (2006) 317-324
22. Tanooka H. Threshold dose-response in radiation carcinogenesis: an approach from chronic beta-irradiation experiments and a review of non-tumour doses. Int J Radiat Biol 77 (2001) 541-551
23. Rothkamm K., and Löbrich M. Evidence of lack of DNA double-strand break repair in human celles exposed to very low x-ray doses. Proc Natl Acad Sci USA 100 (2003) 5057-5062
24. Löbrich M., Rief N., Künne M., et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci USA 102 (2005) 8984-8989
25. Bishay K., Orv K., Olivier M.F., et al. DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation. Carcinogenesis 8 (2001) 1179-1183
26. Amundson S.A., Lee R.A., Koch-Paiz C.A., et al. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res 1 (2003) 445-452
27. Franco N., Lamartine J., Frouin V., et al. Low-dose exposure to gamma rays induces specific gene regulations in normal keratinocytes. Radiat Res 163 (2005) 623-635
28. Cardis E, Vrijheid M, Blettner M, et al. Risk of cancer after low doses of ionizing radiation: retrospective cohort study in 15 countries. BMJ 2005;331:77.
29. Darby S., Hill D., Auvinen A., et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 15 European case-control studies. BMJ 330 (2005) 223-226
30. Taylor C.W., Nisbet A., McGale P., et al. Cardiac exposures in breast cancer radiotherapy: 1950-1990s. Int J Radiat Oncol Biol Phys 69 (2007) 1484-1495
31. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy: a review. Brit J Radiol 62 (1989) 679-694
32. Strandqvist M. Studien über die Cumulative Wirkung der Röntgenstrahlen bei Fraktionierung, Erfahrungen aus dem Radiumhemmet an 280 Haut- und Lippencarzinomen. Acta Radiol 55 Suppl (1994) 1-300
33. Ellis F. The relationship of biological effect to dose-time fractionation factors in radiotherapy. In: Ebert M & Howards A, editors. Current topics in radiation research; 1968.
34. Ash D.V. Breast radiation injury litigation, RAGE Radiotherapy Action Group Exposure. Clin Oncol (R Coll Radiol) 11 (1999) 138-139
35. Mould R.F., Swaine F., and Irwin S. Breast radiation injury litigation (letter). Brit J Radiol 72 (1999) 925
36. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
37. The START Trialist's Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:1098-107.
38. Bartelink H., and Arriagada R. Hypofractionation in radiotherapy for breast cancer. Lancet 371 (2008) 1050-1052
39. Lövey K., Fodor J., Major T., et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy-4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 724-731
40. De Vathaire F., Hawkins M., Campbell S., et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 79 (1999) 1884-1893
41. Menu-Branthomme, Rubino C., Shamsaldin A., et al. Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer 110 (2004) 87-93
42. Guerin S., Guibout C., Shamsaldin A., et al. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study. Int J Cancer 120 (2007) 96-102
43. Nguyen F., Rubino C., Guerin S., et al. Risk of second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70 (2008) 908-915
44. Sandeep T.C., Strachan M.W., Reynolds R.M., et al. Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinal Metab 91 (2006) 1819-1825
45. Rubino C., de Vathaire F., Dottorini M.E., et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 89 (2003) 1638-1644
46. Sagstuen H., Aass N., Fosså S.D., et al. Blood pressure and body mass index in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 4980-4990
47. Curtis RE, Freedman DM, Ron E, et al. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, NIH Publ No. 05-5302, Bethesda, MD; 2006.
48. Nord C., Ganz P.A., Aziz N., et al. Follow-up of long-term cancer survivors in the Nordic countries. Acta Oncol 46 (2007) 433-440